IMMUNOCELLULAR THERAPEUTICS, LTD. INDEPENDENT DIRECTOR AGREEMENT Dated as of April 29, 2022Independent Director Agreement • August 10th, 2022 • ImmunoCellular Therapeutics, Ltd. • Pharmaceutical preparations • Arkansas
Contract Type FiledAugust 10th, 2022 Company Industry JurisdictionThis Independent Director Agreement (this “Agreement”), dated and made effective as of the date first set forth above (the “Effective Date”), is entered into by and between ImmunoCellular Therapeutics, Ltd., a Delaware Corporation (“Company”), and ______________, an individual resident of the State of ____________ (“Director”). The Company and Director may be referred to herein individually as a “Party” or collectively as the “Parties”.
Jupiter Neurosciences, Inc. Independent Director Agreement John Ditton Dated as of September 8, 2021Independent Director Agreement • October 12th, 2021 • Jupiter Neurosciences, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 12th, 2021 Company Industry JurisdictionThis Independent Director Agreement (this “Agreement”), dated and made effective as of the date first set forth above (the “Effective Date”), is entered into by and between Jupiter Neurosciences, Inc., a Delaware Corporation (“Company”), and John Ditton, an individual resident of the State of Nevada (“Director”). The Company and Director may be referred to herein individually as a “Party” or collectively as the “Parties”.
Jupiter Neurosciences, Inc. Independent Director Agreement Allison W. Brady Dated as of September 8, 2021Independent Director Agreement • October 12th, 2021 • Jupiter Neurosciences, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 12th, 2021 Company Industry JurisdictionThis Independent Director Agreement (this “Agreement”), dated and made effective as of the date first set forth above (the “Effective Date”), is entered into by and between Jupiter Neurosciences, Inc., a Delaware Corporation (“Company”), and Allison W. Brady, an individual resident of the State of Pennsylvania (“Director”). The Company and Director may be referred to herein individually as a “Party” or collectively as the “Parties”.
Jupiter Neurosciences, Inc. Independent Director Agreement Julie Kampf Dated as of September 8, 2021Independent Director Agreement • October 12th, 2021 • Jupiter Neurosciences, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 12th, 2021 Company Industry JurisdictionThis Independent Director Agreement (this “Agreement”), dated and made effective as of the date first set forth above (the “Effective Date”), is entered into by and between Jupiter Neurosciences, Inc., a Delaware Corporation (“Company”), and Julie Kampf, an individual resident of the State of Florida (“Director”). The Company and Director may be referred to herein individually as a “Party” or collectively as the “Parties”.
Jupiter Neurosciences, Inc. Independent Director Agreement Nicholas Hemmerly Dated as of September 8, 2021Independent Director Agreement • October 12th, 2021 • Jupiter Neurosciences, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 12th, 2021 Company Industry JurisdictionThis Independent Director Agreement (this “Agreement”), dated and made effective as of the date first set forth above (the “Effective Date”), is entered into by and between Jupiter Neurosciences, Inc., a Delaware Corporation (“Company”), and Nicholas Hemmerly, an individual resident of the State of New York (“Director”). The Company and Director may be referred to herein individually as a “Party” or collectively as the “Parties”.
Jupiter Neurosciences, Inc. Independent Director Agreement Holger Weis Dated as of September 8, 2021Independent Director Agreement • October 12th, 2021 • Jupiter Neurosciences, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 12th, 2021 Company Industry JurisdictionThis Independent Director Agreement (this “Agreement”), dated and made effective as of the date first set forth above (the “Effective Date”), is entered into by and between Jupiter Neurosciences, Inc., a Delaware Corporation (“Company”), and Holger Weis, an individual resident of the State of Florida (“Director”). The Company and Director may be referred to herein individually as a “Party” or collectively as the “Parties”.